Working… Menu

Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03472950
Recruitment Status : Recruiting
First Posted : March 21, 2018
Last Update Posted : June 13, 2019
Gilead Sciences
Information provided by (Responsible Party):
Jeffrey Statland, University of Kansas Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 1, 2019
Estimated Study Completion Date : November 1, 2019